1. Home
  2. BIO vs DCI Comparison

BIO vs DCI Comparison

Compare BIO & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • DCI
  • Stock Information
  • Founded
  • BIO 1952
  • DCI 1915
  • Country
  • BIO United States
  • DCI United States
  • Employees
  • BIO N/A
  • DCI N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • DCI Pollution Control Equipment
  • Sector
  • BIO Industrials
  • DCI Industrials
  • Exchange
  • BIO Nasdaq
  • DCI Nasdaq
  • Market Cap
  • BIO 6.0B
  • DCI 7.9B
  • IPO Year
  • BIO N/A
  • DCI 1987
  • Fundamental
  • Price
  • BIO $257.04
  • DCI $70.90
  • Analyst Decision
  • BIO Strong Buy
  • DCI Hold
  • Analyst Count
  • BIO 4
  • DCI 3
  • Target Price
  • BIO $324.25
  • DCI $70.00
  • AVG Volume (30 Days)
  • BIO 374.5K
  • DCI 549.5K
  • Earning Date
  • BIO 07-31-2025
  • DCI 08-27-2025
  • Dividend Yield
  • BIO N/A
  • DCI 1.70%
  • EPS Growth
  • BIO N/A
  • DCI N/A
  • EPS
  • BIO N/A
  • DCI 2.99
  • Revenue
  • BIO $2,541,100,000.00
  • DCI $3,645,600,000.00
  • Revenue This Year
  • BIO N/A
  • DCI $3.11
  • Revenue Next Year
  • BIO $3.49
  • DCI $3.41
  • P/E Ratio
  • BIO N/A
  • DCI $23.60
  • Revenue Growth
  • BIO N/A
  • DCI 3.26
  • 52 Week Low
  • BIO $211.43
  • DCI $57.45
  • 52 Week High
  • BIO $387.99
  • DCI $78.95
  • Technical
  • Relative Strength Index (RSI)
  • BIO 65.41
  • DCI 54.35
  • Support Level
  • BIO $245.87
  • DCI $70.11
  • Resistance Level
  • BIO $264.68
  • DCI $72.24
  • Average True Range (ATR)
  • BIO 7.34
  • DCI 1.01
  • MACD
  • BIO 1.84
  • DCI 0.09
  • Stochastic Oscillator
  • BIO 78.94
  • DCI 62.80

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.6 billion in revenue and $544 million in operating income in its fiscal 2024.

Share on Social Networks: